PHMC Addresses Concerns Over Niagara with Investments; Volunteers Call for Forumby Mark Eisenberg 08.01.2024Volunteers of U.S. Brig Niagara concerned about ship's future despite PHMC's announcement of upgrades and funding allocation. Transparency demanded.
New Funding Sources Fuel Growth for Early-Stage Fintech Startupsby Terry Bingman 07.01.2024Read about Foxe Capital's new venture fund, Exponent Founders Capital's $75M second fund, HSBC's Zing app, the Synapse controversy, and ...
Investing in New Hampshire Companies: A Lucrative Opportunityby Mark Eisenberg 07.01.2024Investing in early-stage companies in New Hampshire and across New England, Launch New Hampshire aims to develop an innovation ecosystem ...
St. Johns County Invests $1.4m in Playground Upgradesby Mark Eisenberg 07.01.2024St. Johns County invests $1.4M in playground upgrades, including an all-inclusive playground at Aberdeen Park, driven by community engagement.
Robin AI CEO defends AI, denies responsibility for courtroom mistakesby John Darbie 06.01.2024The Role of AI in Automating Legal Tasks: Richard Robinson, CEO of RobinAI, discusses the benefits and importance of human ...
The Slow Progress of Investing in Psychedelicsby Terry Bingman 06.01.2024The growing acceptance of psychedelics in mainstream medicine is being driven by research, funding, and influential backers, despite financial concerns ...
Global startup funding falls, AI boom thrivesby Lilu Anderson 05.01.2024Global startup funding reached its lowest point in 5 years at $285 billion in 2023, reflecting a 38% decline from ...
TCG Crossover’s $1B TCGX Fund II: A Game-Changing TCG Investment Opportunityby Mark Eisenberg 05.01.2024TCG Crossover, a prominent life sciences-focused investment firm, has closed its second fund, TCGX Fund II, with $1 billion in ...
CRISPR QC’s Series A Round Secures Funding from Xcellerant Venturesby John Darbie 05.01.2024San Diego-based CRISPR QC secures Series A funding from Xcellerant Ventures, driving further developments in its CRISPR Analytics Platform.
Global VC Deals Reach New High on January 5th, 2024by Mark Eisenberg 05.01.2024OnCusp Therapeutics raises $100M in Series A funding to advance its research and development efforts in innovative therapeutics. #biotech #funding